baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database

There are paucity of data on gender-based differences in the effect of thrombocytopenia and coronary heart disease (chd) towards development of acute coronary syndrome (acs). we used national inpatient sample (nis) database of the united states to assess the gender-based differences in the association of thrombocytopenia with chd and the impact of thrombocytopenia on mortality, length of stay and hospitalization costs on acs subgroup of chd. our analysis found that thrombocytopenia was associated with increased odds of chd on univariate (odds ratio [or] 1.31 (95% ci 1.30–1.32) p < 0.001) and multivariate (or 1.36 (95% ci 1.34–1.38) p < 0.001) analyses. thrombocytopenic chd patients had increased odds of developing acs only in women (or 1.15, 95% ci 1.12–1.17, p < 0.001). thrombocytopenia was found to be associated with poor short-term outcome in acs subgroup of chd with higher in-hospital mortality (or 1.64, ci 1.58 to 1.71, p < 0.001), length of stay (3.4 days, ci 3.30–3.52, p < 0.001), and cost of hospitalization ($55,652, ci 53,717–57,587, p < 0.001). thrombocytopenic women with acs have greater odds of mortality compared to men. our study suggests that thrombocytopenia among women with chd is associated with increased odds of developing acs. women with acs have greater mortality compared to men. thrombocytopenic acs patients have worse in-hospital outcome compared to patients with normal platelet count. we demonstrated association only and is not possible to establish causality with our study.